KANT logo

Kineta Stock Price

Symbol: OTCPK:KANTMarket Cap: US$4.6mCategory: Pharmaceuticals & Biotech

KANT Share Price Performance

US$0.34
-0.25 (-43.04%)
US$0.34
-0.25 (-43.04%)
Price US$0.34

KANT Community Narratives

There are no narratives available yet.

Recent KANT News & Updates

No updates

Kineta, Inc. Key Details

US$0

Revenue

US$3.3m

Cost of Revenue

-US$3.3m

Gross Profit

US$5.3m

Other Expenses

-US$8.6m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.63
Gross Margin
0%
Net Profit Margin
0%
Debt/Equity Ratio
-13.1%

Kineta, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About KANT

Founded
n/a
Employees
5
CEO
n/a
WebsiteView website
kinetabio.com

Kineta, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies that transform patients’ lives in the United States. The company's immuno-oncology pipeline includes KVA12123, a VISTA blocking immunotherapy in development as a twice weekly monoclonal antibody (mAb) infusion drug. KVA12123 is being evaluated in a Phase 1/2 clinical trial as a monotherapy and in combination with pembrolizumab in patients with advanced solid tumors, including non-small cell lung, ovarian, renal cell carcinoma, head and neck, renal cell, and colorectal cancers. It also developing anti-CD27 agonist mAb immunotherapy to address the problem of exhausted T cells. It has collaboration and license agreements with MSD International Business GmbH, Genentech, Inc., Merck &Co., Inc., FAIR Therapeutics B.V., and GigaGen, Inc. Kineta, Inc. is headquartered in Mercer Island, Washington.

U.S. Market Performance

  • 7 Days: 0.2%
  • 3 Months: 12.2%
  • 1 Year: 19.9%
  • Year to Date: 7.6%
The Consumer Staples sector gained 3.2% while the market remained flat over the last week. As for the longer term, the market has risen 20% in the past 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading